Stifel Financial Corp Applied Genetic Technologies Corp Transaction History

Stifel Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.29 - $0.89 $2,755 - $8,455	9,500 Added 11.76%	90,269 $25,000
Q2 2022 Aug 15, 2022	BUY	$0.62 - $1.1 $39,804 - $70,620	64,200 Added 387.47%	80,769 $62,000
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $63,785 - $99,260	-34,110 Reduced 67.31%	16,569 $31,000
Q3 2021 Nov 15, 2021	SELL	$3.01 - $4.12 $105,018 - $143,746	-34,890 Reduced 40.77%	50,679 $152,000
Q2 2021 Aug 13, 2021	BUY	$3.62 - $5.23 $145,705 - $210,507	40,250 Added 88.81%	85,569 $335,000
Q1 2021 May 14, 2021	BUY	$3.94 - $8.19 $22,631 - $47,043	5,744 Added 14.51%	45,319 $230,000
Q4 2020 Feb 12, 2021	BUY	$3.99 - $5.7 $157,904 - $225,577	39,575 New	39,575 $162,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.